Annual Prostate Cancer Screening Has Little Impact on Mortality Rates, Study Finds

Annual Prostate Cancer Screening Has Little Impact on Mortality Rates, Study Finds
Annual screening for prostate cancer (PC) shows few differences in mortality rates, but does indicate the need to focus on men who will likely die of the disease, according to results from a 15-year follow-up study. From 1993 to 2001, 10 academic medical centers in the U.S. screened 76,685 men and 78,216 women enrolled in the Prostate,

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

One comment

  1. Lawrence Glickman says:

    This article is quite misleading as it is far to general and draws conclusions that have little relevance to the individual patient diagnosed at any age. Further If this in any way discourages regular PSA exams for men over 35 it will certainly cause some men to miss early treatment options and be forced into more radical procedures with less chance of a cure and greater side effects.

Leave a Comment

Your email address will not be published. Required fields are marked *